Real-world effectiveness of pazopanib in patients with intermediate prognostic risk advanced renal cell carcinoma (PRINCIPAL study)
Authors
Procopio, GBamias, A
Schmidinger, M
Hawkins, Robert E
Sanchez, A
Vazquez, S
Srihari, N
Kalofonos, H
Bono, P
Pisal, C
Hirschberg, Y
Dezzani, L
Ahmad, Q
Rodriguez, C
Jonasch, E
Affiliation
Medical Oncology, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, ItalyIssue Date
2018
Metadata
Show full item recordCitation
Procopio G, Bamias A, Schmidinger M, Hawkins R, Rodriguez Sanchez A, Vazquez S, et al. 884P Real-world effectiveness of pazopanib in patients with intermediate prognostic risk advanced renal cell carcinoma (PRINCIPAL study). Ann Oncol. 2018;29(suppl_8):313.Journal
Annals of OncologyDOI
10.1093/annonc/mdy283.093Additional Links
https://dx.doi.org/10.1093/annonc/mdy283.093Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdy283.093